Document:

Exhibit 10.5

 

THIS INSTRUMENT AND
ANY SECURITIES ISSUABLE PURSUANT HERETO HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED,
PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT OR AN EXEMPTION THEREFROM.

 

Nano-Textile Ltd.

 

SAFE 

(Simple Agreement
for Future Equity)

 

THIS CERTIFIES THAT
in exchange for the payment by Fashion For Good B.V., a private company with limited liability, incorporated
under the laws of the Netherlands, having its corporate seat in Rokin 102, 1012 KZ Amsterdam,
the Netherlands, and registered at the Dutch Commercial Register under number 6696074
(the “Investor”) of €100,000 (the “Purchase Amount”) on or about 18 October,
2018, Nano-Textile Ltd., an Israeli corporation (the “Company”), hereby issues to the Investor the right to
certain shares of the Company’s capital stock, subject to the terms set forth below.

 

The “Valuation
Cap” is $US7,000,000.

 

The “Discount
Rate” is 80%.

 

See Section 2
for certain additional defined terms.

 

1.       Events

 

          (a)          Equity
Financing. If there is an Equity Financing before the expiration or termination of this instrument, the Company will automatically
issue to the Investor a number of shares of Safe Preferred Stock equal to the Purchase Amount divided by the Conversion Price.

 

          In
connection with the issuance of Safe Preferred Stock by the Company to the Investor pursuant to this Section 1(a):

 

(i) The Investor will
execute and deliver to the Company all transaction documents related to the Equity Financing; provided, that such documents
are the same documents to be entered into with the purchasers of Standard Preferred Stock, with appropriate variations for the
Safe Preferred Stock if applicable, and provided further, that such documents have customary exceptions to any drag-along
applicable to the Investor, including, without limitation, limited representations and warranties and limited liability and indemnification
obligations on the part of the Investor.

 

          (b)          Liquidity
Event. If there is a Liquidity Event before the expiration or termination of this instrument, the Investor will, at its
option, either (i) receive a cash payment equal to one-hundred percent (100%) of the Purchase Amount (subject to the following
paragraph) or (ii) automatically receive from the Company a number of shares of Common Stock equal to the Purchase Amount divided
by the Liquidity Price, if the Investor fails to select the cash option.

 

In connection with
Section (b)(i), one-hundred percent (100%) of the Purchase Amount will be due and payable by the Company to the Investor immediately
prior to, or concurrent with, the consummation of the Liquidity Event. If there are not enough funds to pay the Investor and holders
of other Safes (collectively, the “Cash-Out Investors”) in full, then all of the Company’s available
funds will be distributed with equal priority and pro rata among the Cash-Out Investors in proportion to their Purchase
Amounts, and the Cash-Out Investors will automatically receive the number of shares of Common Stock equal to the remaining unpaid
Purchase Amount divided by the Liquidity Price. In connection with a Change of Control intended to qualify as a tax-free reorganization,
the Company may reduce, pro rata, the Purchase Amounts payable to the Cash-Out Investors by the amount determined by its
board of directors in good faith to be advisable for such Change of Control to qualify as a tax-free reorganization for U.S. federal
income tax purposes, and in such case, the Cash-Out Investors will automatically receive the number of shares of Common Stock
equal to the remaining unpaid Purchase Amount divided by the Liquidity Price.

 

     

     

    

 

          (c)          Dissolution
Event. If there is a Dissolution Event before this instrument expires or terminates, the Company will pay an amount equal
to the Purchase Amount, due and payable to the Investor immediately prior to, or concurrent with, the consummation of the Dissolution
Event. The Purchase Amount will be paid prior and in preference to any Distribution of any of the assets of the Company to holders
of outstanding Capital Stock by reason of their ownership thereof. If immediately prior to the consummation of the Dissolution
Event, the assets of the Company legally available for distribution to the Investor and all holders of all other Safes (the “Dissolving
Investors”), as determined in good faith by the Company’s board of directors, are insufficient to permit the payment
to the Dissolving Investors of their respective Purchase Amounts, then the entire assets of the Company legally available for
distribution will be distributed with equal priority and pro rata among the Dissolving Investors in proportion to the Purchase
Amounts they would otherwise be entitled to receive pursuant to this Section 1(c).

 

          (d)          Termination.
This instrument will expire and terminate (without relieving the Company of any obligations arising from a prior breach of or
non-compliance with this instrument) upon either (i) the issuance of stock to the Investor pursuant to Section 1(a) or Section
1(b)(ii); or (ii) the payment, or setting aside for payment, of amounts due the Investor pursuant to Section 1(b)(i) or Section
1(c).

 

2.       Definitions

 

          “Capital
Stock” means the capital stock of the Company, including, without limitation, the “Common Stock”
and the “Preferred Stock.”

 

          “Change
of Control” means (i) a transaction or series of related transactions in which any “person” or “group”
(within the meaning of Section 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), becomes the “beneficial
owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended), directly or indirectly, of more
than 50% of the outstanding voting securities of the Company having the right to vote for the election of members of the Company’s
board of directors, (ii) any reorganization, merger or consolidation of the Company, other than a transaction or series of
related transactions in which the holders of the voting securities of the Company outstanding immediately prior to such transaction
or series of related transactions retain, immediately after such transaction or series of related transactions, at least a majority
of the total voting power represented by the outstanding voting securities of the Company or such other surviving or resulting
entity or (iii) a sale, lease or other disposition of all or substantially all of the assets of the Company.

 

“Company
Capitalization” means the sum, as of immediately prior to the Equity Financing, of: (1) all shares
of Capital Stock (on an as-converted basis) issued and outstanding, assuming exercise or conversion of all outstanding vested
and unvested options, warrants, and other convertible securities (which includes all Safes and convertible promissory notes issued
with a lower valuation cap than the SAFE); but excluding (A) this instrument, (B) all other Safes and convertible
promissory notes issued at a valuation cap equal to or higher than the Valuation Cap in the SAFE; and (2)
all shares of Common Stock reserved and available for future grant under any equity incentive or similar plan of the Company,
and/or any equity incentive or similar plan to be created or increased in connection with the Equity Financing.

 

          “Conversion
Price” means the either: (1) the Safe Price or (2) the Discount Price, whichever calculation results in a greater number
of shares of Safe Preferred Stock.

 

    	 	- 2 -	 

     

    

 

          “Discount
Price” means the price per share of the Standard Preferred Stock sold in the Equity Financing multiplied by the Discount
Rate.

 

          “Distribution”
means the transfer to holders of Capital Stock by reason of their ownership thereof of cash or other property without consideration
whether by way of dividend or otherwise, other than dividends on Common Stock payable in Common Stock, or the purchase or redemption
of Capital Stock by the Company or its subsidiaries for cash or property other than: (i) repurchases of Common Stock held
by employees, officers, directors or consultants of the Company or its subsidiaries pursuant to an agreement providing, as applicable,
a right of first refusal or a right to repurchase shares upon termination of such service provider’s employment or services;
or (ii) repurchases of Capital Stock in connection with the settlement of disputes with any stockholder.

 

          “Dissolution
Event” means (i) a voluntary termination of operations, (ii) a general assignment for the benefit of the Company’s
creditors or (iii) any other liquidation, dissolution or winding up of the Company (excluding a Liquidity Event),
whether voluntary or involuntary.

 

          “Equity
Financing” means a bona fide transaction or series of transactions with the principal purpose of raising capital, pursuant
to which the Company issues and sells Preferred Stock at a fixed pre-money valuation, with an aggregate sales price of not less
than $1,000,000 (excluding all Converting Securities). If the securities to be issued by the Company in any bona fide transaction
or series of transactions with the principal purpose of raising capital are shares of Common Stock, the Investor shall have the
right, but not the obligation, to treat such transaction or series of related transactions as an Equity Financing for purposes
of Section 1. If the aggregate sales price is less than $1,000,000 the Investor shall have the right, but not the obligation,
to treat such transaction or series of related transactions as an Equity Financing for purposes of Section 1.

 

          “Initial
Public Offering” means the closing of the Company’s first firm commitment underwritten initial public offering
of Common Stock pursuant to a registration statement filed under the Securities Act.

 

          “Liquidity
Capitalization” means the number, as of immediately prior to the Liquidity Event, of shares of Capital Stock (on an
as-converted basis) outstanding, assuming exercise or conversion of all outstanding vested and unvested options, warrants and
other convertible securities, but excluding: (i) shares of Common Stock reserved and available for future grant
under any equity incentive or similar plan; (ii) this instrument; (iii) other Safes; and (iv) convertible promissory notes.

 

          “Liquidity
Event” means a Change of Control or an Initial Public Offering.

 

          “Liquidity
Price” means the price per share equal to the Valuation Cap divided by the Liquidity Capitalization.

 

          
“Safe” means an instrument containing a future right to shares of Capital Stock, similar in form and content
to this instrument, purchased by investors for the purpose of funding the Company’s business operations.

 

          “Safe
Preferred Stock” means the shares of a series of Preferred Stock issued to the Investor in an Equity Financing, having
the identical rights, privileges, preferences and restrictions as the shares of Standard Preferred Stock, other than with respect
to: (i) the per share liquidation preference and the conversion price for purposes of price-based anti-dilution protection, which
will equal the Conversion Price; and (ii) the basis for any dividend rights, which will be based on the Conversion Price.

 

          “Safe
Price” means the price per share equal to the Valuation Cap divided by the Company Capitalization.

 

    	 	- 3 -	 

     

    

 

          “Standard
Preferred Stock” means the shares of a series of Preferred Stock issued to the investors investing new money in the
Company in connection with the initial closing of the Equity Financing.

 

3.       Company
Representations

 

          (a)          The
Company is a corporation duly organized, validly existing and in good standing under the laws of the state of its incorporation,
and has the power and authority to own, lease and operate its properties and carry on its business as now conducted.

 

          (b)          The
execution, delivery and performance by the Company of this instrument is within the power of the Company and, other than with
respect to the actions to be taken when equity is to be issued to the Investor, has been duly authorized by all necessary actions
on the part of the Company. This instrument constitutes a legal, valid and binding obligation of the Company, enforceable against
the Company in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating
to or affecting the enforcement of creditors’ rights generally and general principles of equity. To the knowledge of the
Company, it is not in violation of (i) its current certificate of incorporation or bylaws, (ii) any material statute, rule or
regulation applicable to the Company or (iii) any material indenture or contract to which the Company is a party or by which it
is bound, where, in each case, such violation or default, individually, or together with
all such violations or defaults, could reasonably be expected to have a material adverse effect on the Company.

 

          (c)          The
performance and consummation of the transactions contemplated by this instrument do not and will not: (i) violate any material
judgment, statute, rule or regulation applicable to the Company; (ii) result in the acceleration of any material indenture
or contract to which the Company is a party or by which it is bound; or (iii) result in the creation or imposition of any
lien upon any property, asset or revenue of the Company or the suspension, forfeiture, or nonrenewal of any material permit, license
or authorization applicable to the Company, its business or operations.

 

          (d)          No
consents or approvals are required in connection with the performance of this instrument, other than: (i) the Company’s
corporate approvals; (ii) any qualifications or filings under applicable securities laws; and (iii) necessary corporate approvals
for the authorization of Capital Stock issuable pursuant to Section 1.

 

          (e)          To
its knowledge, the Company owns or possesses (or can obtain on commercially reasonable terms) sufficient legal rights to all patents,
trademarks, service marks, trade names, copyrights, trade secrets, licenses, information, processes and other intellectual property
rights necessary for its business as now conducted and as currently proposed to be conducted, without any conflict with, or infringement
of the rights of, others.

 

4.       Investor
Representations

          

          (a)          The
Investor has full legal capacity, power and authority to execute and deliver this instrument and to perform its obligations hereunder.
This instrument constitutes valid and binding obligation of the Investor, enforceable in accordance with its terms, except as
limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement of creditors’
rights generally and general principles of equity.

 

          (b)          The
Investor is an accredited investor as such term is defined in Rule 501 of Regulation D under the Securities Act. The
Investor has been advised that this instrument and the underlying securities have not been registered under the Securities Act,
or any state securities laws and, therefore, cannot be resold unless they are registered under the Securities Act and applicable
state securities laws or unless an exemption from such registration requirements is available. The Investor is purchasing this
instrument and the securities to be acquired by the Investor hereunder for its own account for investment, not as a nominee or
agent, and not with a view to, or for resale in connection with, the distribution thereof, and the Investor has no present intention
of selling, granting any participation in, or otherwise distributing the same. The Investor has such knowledge and experience
in financial and business matters that the Investor is capable of evaluating the merits and risks of such investment, is able
to incur a complete loss of such investment without impairing the Investor’s financial condition and is able to bear the
economic risk of such investment for an indefinite period of time.

 

    	 	- 4 -	 

     

    

 

5.       Miscellaneous

 

          (a)          Any
provision of this instrument may be amended, waived or modified only upon the written consent of the Company and the Investor.

 

          (b)          Any
notice required or permitted by this instrument will be deemed sufficient when delivered personally or by courier or sent by email
to the relevant address listed on the signature page, or after being deposited in the mail as certified or registered mail with
postage prepaid and return receipt requested, addressed to the party to be notified at such party’s address listed on the
signature page, as subsequently modified by written notice.

 

          (c)          The
Investor is not entitled, as a holder of this instrument, to vote or receive dividends or be deemed the holder of Capital Stock
for any purpose, nor will anything contained herein be construed to confer on the Investor, as such, any of the rights of a stockholder
of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting
thereof, or to give or withhold consent to any corporate action or to receive notice of meetings, or to receive subscription rights
or otherwise until shares have been issued upon the terms described herein.

 

          (d)          Neither
this instrument nor the rights contained herein may be assigned, by operation of law or otherwise, by either party without the
prior written consent of the other; provided, however, that this instrument and/or the rights contained herein may be assigned
without the Company’s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by
or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or
director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners
or managing members of, or shares the same management company with, the Investor; and provided, further, that the Company
may assign this instrument in whole, without the consent of the Investor, in connection with a reincorporation to change the Company’s
domicile.

 

          (e)          In
the event any one or more of the provisions of this instrument is for any reason held to be invalid, illegal or unenforceable,
in whole or in part or in any respect, or in the event that any one or more of the provisions of this instrument operate or would
prospectively operate to invalidate this instrument, then and in any such event, such provision(s) only will be deemed null and
void and will not affect any other provision of this instrument and the remaining provisions of this instrument will remain operative
and in full force and effect and will not be affected, prejudiced, or disturbed thereby.

 

          (f)          All
rights and obligations hereunder will be governed by the laws of the State of Israel, without regard to the conflicts of law provisions
of such jurisdiction. The Company and Investor hereby irrevocably submit to the jurisdiction of the courts of the State of Israel
situated in Tel Aviv to adjudicate any dispute arising out of or relating to this letter agreement.

 

(Signature page follows)

 

    	 	- 5 -	 

     

    

 

IN WITNESS WHEREOF, the undersigned have
caused this instrument to be duly executed and delivered.

 

	 	Nano-Textile Ltd.
	 	 
	 	By:	                       
	 	 
	 	Mr. Joshua Herchcovici, Founder and Chairman
	 	 
	 	Address: Menachem Begin 3, Ramat Gan, Israel
	 	Email:sh@shaysapir.com
	 	 
	 	 
	 	INVESTOR: 
	Fashion For Good B.V.	 
	 	By:	 
	 	Name: Katrin Ley, Managing Director
	 	 
	 	By:	 
	 	Name: Angela Schuler-Keiser, General Proxy Holder
	 	 
	 	Address: Rokin 102, 1012 KZ Amsterdam, 
	 	The Netherlands
	 	 
	 	Email: katrin.ley@fashionforgood.com; 
	 	a.schuler@cofraholding.com;
    
	 	rogier.vanmazijk@fashionforgood.comExhibit 10.6

 

NANO-TEXTILE LTD.

RESTRICTED STOCK PURCHASE
AGREEMENT

 

This Restricted Stock
Purchase Agreement (the “Agreement”) is made as of 18 October, 2018 by and between Nano-Textile Ltd.,
an Israeli corporation (the “Company”), and Fashion For Good B.V., a private
company with limited liability, incorporated under the laws of the Netherlands, having its corporate seat in Rokin
102, 1012 KZ Amsterdam, the Netherlands, and registered at the Dutch Commercial Register
under number 6696074  (the “Purchaser”).

 

In consideration of
the mutual covenants and representations set forth below, the Company and the Purchaser agree as follows:

 

		1.	Purchase and Sale of the Shares.

A.           
Subject to the terms and conditions of this Agreement, the Company agrees to sell to the Purchaser 781,879 shares of the
Company’s Common Stock for an aggregate purchase price of $64,661.39 ($0.0827 per share), in exchange for the value of the
Services rendered by Purchaser to the Company in the Advisor Agreement attached hereto.

 

		2.	Restrictions on Transfer.

A.           
Investment Representations and Legend Requirements. The Purchaser hereby makes the investment representations
listed on Exhibit A to the Company as of the date of this Agreement, and agrees that such representations are incorporated
into this Agreement by this reference, such that the Company may rely on them in issuing the Shares and for any other lawful purpose.
The Purchaser understands and agrees that the Company shall cause the legends set forth below, or substantially equivalent legends,
to be placed upon any certificate(s) evidencing ownership of the Shares, together with any other legends that may be required by
the Company or by applicable state or federal securities laws:

 

THE SECURITIES REPRESENTED
HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND MAY NOT
BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION
OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES
WITH THE ACT.

 

THE SHARES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER, A RIGHT OF FIRST REFUSAL AND A LOCK-UP PERIOD IN THE EVENT
OF A PUBLIC OFFERING AS SET FORTH IN THE RESTRICTED STOCK PURCHASE AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE
SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH TRANSFER RESTRICTIONS, RIGHT OF FIRST REFUSAL
AND LOCK-UP PERIOD ARE BINDING ON TRANSFEREES OF THESE SHARES.

 

B.            
Stop-Transfer Notices. The Purchaser agrees that to ensure compliance with the restrictions referred to herein,
the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any, and that, if the Company
transfers its own securities, it may make appropriate notations to the same effect in its own records.

 

     

     

    

 

C.            
Refusal to Transfer. The Company shall not be required (i) to transfer on its books any Shares that have
been sold or otherwise transferred in violation of any of the provisions of this Agreement or (ii) to treat as owner of such
Shares or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares shall have been
so transferred.

 

D.           
Lock-Up Period. The Purchaser hereby agrees that the Purchaser shall not sell, offer, pledge, contract to
sell, grant any option or contract to purchase, purchase any option or contract to sell, grant any right or warrant to purchase,
lend or otherwise transfer or encumber, directly or indirectly, any Shares or other securities of the Company, nor shall the Purchaser
enter into any swap, hedging or other arrangement that transfers to another, in whole or in part, any of the economic consequences
of ownership of any Shares or other securities of the Company, during the period from the filing of the first registration statement
of the Company filed under the Securities Act of 1933, as amended (the “Securities Act”), that includes
securities to be sold on behalf of the Company to the public in an underwritten public offering under the Securities Act through
the end of the 180-day period following the effective date of such registration statement (or such other period as may be requested
by the Company or the underwriters to accommodate regulatory restrictions on (i) the publication or other distribution of
research reports and (ii) analyst recommendations and opinions, including, but not limited to, the restrictions contained
in NASD Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments thereto). The Purchaser further
agrees, if so requested by the Company or any representative of its underwriters, to enter into such underwriter’s standard
form of “lockup” or “market standoff” agreement in a form satisfactory to the Company and such underwriter.
The Company may impose stop-transfer instructions with respect to securities subject to the foregoing restrictions until the end
of any such restriction period.

 

E.            
Shares; Right of First Refusal. No Shares purchased pursuant to this Agreement, nor any beneficial interest in
such Shares, shall be sold, transferred, encumbered or otherwise disposed of in any way (whether by operation of law or otherwise)
by the Purchaser or any subsequent transferee, other than in compliance with the Company’s right of first refusal provisions
contained in Section 3 of this Agreement.

 

F.            
No Transfers to Bad Actors .
The Purchaser agrees not to sell, assign, transfer, pledge, encumber or otherwise dispose of any securities of the Company, or
any beneficial interest therein, to any person (other than the Company) unless and until the proposed transferee confirms to the
reasonable satisfaction of the Company that neither the proposed transferee nor any of its directors, executive officers, other
officers that may serve as a director or officer of any company in which it invests, general partners or managing members nor any
person that would be deemed a beneficial owner of those securities (in accordance with Rule 506(d) of the Securities Act) is subject
to any of the “bad actor” disqualifications described in Rule 506(d)(1)(i) through (viii) under the Securities Act
(“Bad Actor Disqualifications”), except as set forth in Rule 506(d)(2)(ii) or (iii) or (d)(3) under the
Securities Act and disclosed, reasonably in advance of the transfer, in writing in reasonable detail to the Company. The Purchaser
will promptly notify the Company in writing if the Purchaser or, to the Purchaser’s knowledge, any person specified in Rule
506(d)(1) under the Securities Act becomes subject to any Bad Actor Disqualification.

 

G.           
Restrictions Binding on Transferees. All transferees of Shares or any interest therein shall receive and hold
such Shares or interest subject to all of the provisions of this Agreement, and there shall be no further transfer of such Shares
except in accordance with the terms of this Agreement.

 

    	 	2	 

     

    

 

3.            Company’s
Right of First Refusal. Before any Shares acquired by the Purchaser pursuant to this Agreement (or any beneficial interest
in such Shares) may be transferred, encumbered or otherwise disposed of in any way (whether by operation of law or otherwise)
by the Purchaser or any subsequent transferee (each a “Holder”), such Holder must first offer such Shares
or beneficial interest to the Company and/or its assignee(s) as follows:

 

A.           
Notice of Proposed Transfer. The Holder shall deliver to the Company a written notice stating: (i) the
Holder’s bona fide intention to sell or otherwise transfer the Shares; (ii) the name of each proposed transferee;
(iii) the number of Shares to be transferred to each proposed transferee; (iv) the bona fide cash price or other
consideration for which the Holder proposes to transfer the Shares; and (v) that by delivering the notice, the Holder offers
all such Shares to the Company and/or its assignee(s) pursuant to this section and on the same terms described in the notice.

 

B.            
Exercise of Right of First Refusal. At any time within 30 days after receipt of the Holder’s notice,
the Company and/or its assignee(s) may, by giving written notice to the Holder, elect to purchase all, but not less than all, of
the Shares proposed to be transferred to any one or more of the proposed transferees, at the purchase price determined in accordance
with Section 3.C.

 

C.            
Purchase Price. The purchase price for the Shares purchased by the Company and/or its assignee(s) under this
section shall be the price listed in the Holder’s notice. If the price listed in the Holder’s notice includes consideration
other than cash, the cash equivalent value of the non-cash consideration shall be determined by the board of directors of the Company
in its sole discretion.

 

D.           
Payment. Payment of the purchase price shall be made, at the option of the Company and/or its assignee(s),
in cash (by check), by cancellation of all or a portion of any outstanding indebtedness of the Holder to the Company and/or its
assignee(s), or by any combination thereof within 30 days after receipt by the Company of the Holder’s notice (or at
such later date as is called for by such notice).

 

E.            
Holder’s Right to Transfer. If all of the Shares proposed in the notice to be transferred to a given
proposed transferee are not purchased by the Company and/or its assignee(s) as provided in this section, then the Holder may sell
or otherwise transfer such Shares to that proposed transferee; provided that: (i) the transfer is made only on the
terms provided for in the notice, with the exception of the purchase price, which may be either the price listed in the notice
or any higher price; (ii) such transfer is consummated within 60 days after the date the notice is delivered to the Company;
(iii) the transfer is effected in accordance with any applicable securities laws, and if requested by the Company, the Holder
shall have delivered an opinion of counsel acceptable to the Company to that effect; (iv) prior to the transfer, the proposed
transferee confirms to the reasonable satisfaction of the Company that neither the proposed transferee nor any of its directors,
executive officers, other officers that may serve as a director or officer of any company in which it invests, general partners
or managing members nor any person that would be deemed a beneficial owner of those Shares (in accordance with Rule 506(d) of the
Securities Act) is subject to any Bad Actor Disqualification, except as set forth in Rule 506(d)(2)(ii) or (iii) or (d)(3) under
the Securities Act and disclosed, reasonably in advance of the transfer, in writing in reasonable detail to the Company; and (v) the
proposed transferee agrees in writing to receive and hold the Shares so transferred subject to all of the provisions of this Agreement,
including but not limited to this section, and there shall be no further transfer of such Shares except in accordance with the
terms of this section. If any Shares described in a notice are not transferred to the proposed transferee within the period provided
above, then before any such Shares may be transferred, a new notice shall be given to the Company, and the Company and/or its assignees
shall again be offered the right of first refusal described in this section.

 

    	 	3	 

     

    

 

F.            
Involuntary Transfers. Subject to the other provisions of this Section 3, in the event, at any
time after the date of this Agreement, of any transfer by operation of law or other involuntary transfer (including, but not limited
to, transfers by operation of law or other involuntary transfers in connection with a divorce, dissolution, legal separation or
annulment) of all or a portion of the Shares by the record holder thereof that does not occur in accordance with the other provisions
of this Section 3, the Company shall have the right to purchase all of the Shares transferred at the greater of the
purchase price paid by the Purchaser pursuant to this Agreement or the fair market value of the Shares on the date of transfer
(as determined by the board of directors of the Company). Upon such a transfer, the persons transferring or acquiring the Shares
shall promptly notify the Company in writing of such transfer. The right to purchase such Shares shall be provided to the Company
for a period of 30 days following receipt by the Company of written notice of the transfer.

 

G.           
Exception for Certain Family Transfers. Notwithstanding anything to the contrary contained elsewhere in this
section, the transfer of any or all of the Shares during the Holder’s lifetime (except in connection with a divorce, dissolution,
legal separation or annulment), or on the Holder’s death by will or intestacy, to (i) the Holder’s spouse or domestic
partner; (ii) the Holder’s lineal descendants or antecedents, siblings, aunts, uncles, cousins, nieces and nephews (including
adoptive relationships and step relationships), and their spouses or domestic partners; (iii) the lineal descendants or antecedents,
siblings, cousins, aunts, uncles, nieces and nephews of Holder’s spouse or domestic partner (including adoptive relationships
and step relationships), and their spouses or domestic partners; and (iv) a trust or other similar estate planning vehicle for
the benefit of the Holder or any such person, shall be exempt from the provisions of this section; provided that, in each
such case, the transferee agrees in writing to receive and hold the Shares so transferred subject to all of the provisions of this
Agreement, including but not limited to this section, and there shall be no further transfer of such Shares except in accordance
with the terms of this section; and provided further, that without the prior written consent of the Company, which may be
withheld in the sole discretion of the Company, no more than three transfers may be made pursuant to this section, including all
transfers by the Holder and all transfers by any transferee. For purposes of this Agreement, a person will be deemed to be a “domestic
partner” of another person if the two persons (1) reside in the same residence and plan to do so indefinitely, (2) have resided
together for at least one year, (3) are each at least 18 years of age and mentally competent to consent to contract, (4) are not
blood relatives any closer than would prohibit legal marriage in the state in which they reside, (5) are financially interdependent,
as demonstrated to the reasonable satisfaction of the Company and (6) have each been the sole spouse equivalent of the other for
the year prior to the transfer and plan to remain so indefinitely; provided that a person will not be considered a domestic partner
if he or she is married to another person or has any other spouse equivalent.

 

H.           
Termination of Right of First Refusal. The rights contained in this section shall terminate as to all Shares
purchased hereunder upon the earlier of: (i) the closing date of the first sale of Common Stock of the Company to the general
public pursuant to a registration statement filed with and declared effective by the Securities and Exchange Commission under the
Securities Act, and (ii) the closing date of a Change of Control pursuant to which the holders of the outstanding voting securities
of the Company receive securities of a class registered pursuant to Section 12 of the Securities Exchange Act of 1934, as
amended.

 

4.             Tax
Consequences. The Purchaser has reviewed with the Purchaser’s own tax advisors the federal, state, local and foreign
tax consequences of this investment and the transactions contemplated by this Agreement. The Purchaser is relying solely on such
advisors and not on any statements or representations of the Company or any of its agents. The Purchaser understands that the
Purchaser (and not the Company) shall be responsible for any tax liability that may arise as a result of the transactions contemplated
by this Agreement.

 

    	 	4	 

     

    

 

		5.	General Provisions.

A.           
Choice of Law. This Agreement shall be governed by the internal substantive laws, but not the choice of law
rules, of Israel.

 

B.            
Integration. This Agreement, including all exhibits hereto, represents the entire agreement between the parties
with respect to the purchase of the Shares by the Purchaser and supersedes and replaces any and all prior written or oral agreements
regarding the subject matter of this Agreement including, but not limited to, any representations made during any interviews, relocation
discussions or negotiations whether written or oral.

 

C.            
Notices. Any notice, demand, offer, request or other communication required or permitted to be given by either
the Company or the Purchaser pursuant to the terms of this Agreement shall be in writing and shall be deemed effectively given
the earlier of (i) when received, (ii) when delivered personally, (iii) sent by email to the relevant address listed
on the signature page , (iv)  after being deposited with a courier service and confirmation of receipt obtained or (v) 
after being deposited in the mail with postage prepaid and return receipt requested, and addressed to the parties at the addresses
provided to the Company (which the Company agrees to disclose to the other parties upon request) or such other address as a party
may request by notifying the other in writing.

 

D.           
Successors. Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation,
liquidation or otherwise) to all or substantially all of the Company’s business and/or assets shall assume the obligations
under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent
as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement,
the term “Company” shall include any successor to the Company’s business and/or assets which executes
and delivers the assumption agreement described in this section or which becomes bound by the terms of this Agreement by operation
of law. Subject to the restrictions on transfer set forth in this Agreement, this Agreement shall be binding upon the Purchaser
and his or her heirs, executors, administrators, successors and assigns.

 

E.            
Assignment; Transfers. Except as set forth in this Agreement, this Agreement, and any and all rights, duties
and obligations hereunder, shall not be assigned, transferred, delegated or sublicensed by the Purchaser without the prior written
consent of the Company. Any attempt by the Purchaser without such consent to assign, transfer, delegate or sublicense any rights,
duties or obligations that arise under this Agreement shall be void. Except as set forth in this Agreement, any transfers in violation
of any restriction upon transfer contained in any section of this Agreement shall be void, unless such restriction is waived in
accordance with the terms of this Agreement.

 

F.            
Amendments; Waiver. Except as expressly provided herein, neither this Agreement nor any terms hereof may be
amended, waived, discharged or terminated other than by a written instrument referencing this Agreement and signed by the Company
and the Purchaser. Either party’s failure to enforce any provision of this Agreement shall not in any way be construed as
a waiver of any such provision, nor prevent that party from thereafter enforcing any other provision of this Agreement. The rights
granted both parties hereto are cumulative and shall not constitute a waiver of either party’s right to assert any other
legal remedy available to it.

 

G.           
Purchaser Investment Representations and Further Documents. The Purchaser agrees upon request to execute
any further documents or instruments necessary or reasonably desirable in the view of the Company to carry out the purposes or
intent of this Agreement, including (but not limited to) the applicable exhibits and attachments to this Agreement.

 

    	 	5	 

     

    

 

H.           
Severability. Should any provision of this Agreement be found to be illegal or unenforceable, the other provisions
shall nevertheless remain effective and shall remain enforceable to the greatest extent permitted by law.

 

I.              
Rights as Stockholder. Subject to the terms and conditions of this Agreement, the Purchaser shall have all
of the rights of a stockholder of the Company with respect to the Shares from and after the date that the Purchaser delivers a
fully executed copy of this Agreement (including the applicable exhibits and attachments to this Agreement) and full payment for
the Shares to the Company, and until such time as the Purchaser disposes of the Shares in accordance with this Agreement. Upon
such transfer, the Purchaser shall have no further rights as a holder of the Shares so purchased except (in the case of a transfer
to the Company) the right to receive payment for the Shares so purchased in accordance with the provisions of this Agreement, and
the Purchaser shall forthwith cause the certificate(s) evidencing the Shares so purchased to be surrendered to the Company for
transfer or cancellation.

 

J.              
Adjustment for Stock Split. All references to the number of Shares and the purchase price of the Shares in
this Agreement shall be adjusted to reflect any stock split, stock dividend or other change in the Shares which may be made after
the date of this Agreement.

 

K.           
Jurisdiction. The Purchaser and Company irrevocably submit to the jurisdiction of the courts in the State
of Israel situated in Tel Aviv to adjudicate any dispute arising out of or relating to this Agreement.

 

L.            
Reliance on Counsel and Advisors. The Purchaser acknowledges that he or she has had the opportunity to review
this Agreement, including all attachments hereto, and the transactions contemplated by this Agreement with his or her own legal
counsel, tax advisors and other advisors. The Purchaser is relying solely on his or her own counsel and advisors and not on any
statements or representations of the Company or its agents for legal or other advice with respect to this investment or the transactions
contemplated by this Agreement.

 

M.               
Counterparts. This Agreement may be executed in one or more counterparts, each of which will be deemed an
original, but all of which together will constitute one and the same agreement. Facsimile copies of signed signature pages shall
be binding originals.

 

(signature page follows)

    	 	6	 

     

    

 

The parties hereto
represent that they have read this Agreement in its entirety, have had an opportunity to obtain the advice of counsel prior to
executing this Agreement and fully understand this Agreement. The Purchaser agrees to notify the Company of any change in his or
her address below.

 

 

PURCHASER

Fashion For Good B.V.

a Dutch limited liability company

 

 

 

By:                                                     

Name & Title: Katrin Ley, Managing Director

 

By:                                                     

Name & Title: Angela Schuler-Keiser, General Proxy Holder

 

Email: katrin.ley@fashionforgood.com;
a.schuler@cofraholding.com;

rogier.vanmazijk@fashionforgood.com

 

 

 

 

 

NANO-TEXTILE LTD.

 

 

 

                                                        

Signature

 

                                                        

Print Name

 

                                                        

Print Title

 

 

     

     

    

 

Exhibit A

 

INVESTMENT REPRESENTATION
STATEMENT

 

	PURCHASER	:	Fashion For Good B.V.COMPANY	:	Nano-Textile Ltd.
	SECURITY	:	Common Stock	 	 
	AMOUNT	:	781,879 Shares	 	 
	DATE	:	15 October, 2018	 	 

 

 

 

In connection with
the purchase of the above-listed shares, I, the undersigned purchaser, represent to the Company as follows:

 

1.             
The Company may rely on these representations. I understand that the Company’s sale of the shares to
me has not been registered under the Securities Act of 1933, as amended (the “Securities Act”), because
the Company believes, relying in part on my representations in this document, that an exemption from such registration requirement
is available for such sale. I understand that the availability of this exemption depends upon the representations I am making to
the Company in this document being true and correct.

 

2.             
I am purchasing for investment. I am purchasing the shares solely for investment purposes, and not for further
distribution. My entire legal and beneficial ownership interest in the shares is being purchased and shall be held solely for my
account, except to the extent I intend to hold the shares jointly with my spouse. I am not a party to, and do not presently intend
to enter into, any contract or other arrangement with any other person or entity involving the resale, transfer, grant of participation
with respect to or other distribution of any of the shares. My investment intent is not limited to my present intention to hold
the shares for the minimum capital gains period specified under any applicable tax law, for a deferred sale, for a specified increase
or decrease in the market price of the shares, or for any other fixed period in the future.

 

3.             
I can protect my own interests. I can properly evaluate the merits and risks of an investment in the shares
and can protect my own interests in this regard, whether by reason of my own business and financial expertise, the business and
financial expertise of certain professional advisors unaffiliated with the Company with whom I have consulted, or my preexisting
business or personal relationship with the Company or any of its officers, directors or controlling persons.

 

4.             
I am informed about the Company. I am sufficiently aware of the Company’s business affairs and financial
condition to reach an informed and knowledgeable decision to acquire the shares. I have had opportunity to discuss the plans, operations
and financial condition of the Company with its officers, directors or controlling persons, and have received all information I
deem appropriate for assessing the risk of an investment in the shares.

 

5.             
I recognize my economic risk. I realize that the purchase of the shares involves a high degree of risk, and
that the Company’s future prospects are uncertain. I am able to hold the shares indefinitely if required, and am able to
bear the loss of my entire investment in the shares.

 

6.             
I know that the shares are restricted securities. I understand that the shares are “restricted securities”
in that the Company’s sale of the shares to me has not been registered under the Securities Act in reliance upon an exemption
for non-public offerings. In this regard, I also understand and agree that:

A.           
I must hold the shares indefinitely, unless any subsequent proposed resale by me is registered under the Securities Act,
or unless an exemption from registration is otherwise available (such as Rule 144);

B.            
the Company is under no obligation to register any subsequent proposed resale of the shares by me; and

C.            
the certificate evidencing the shares will be imprinted with a legend which prohibits the transfer of the shares unless
such transfer is registered or such registration is not required in the opinion of counsel for the Company.

 

    	 	1	 

     

    

 

7.             
I am familiar with Rule 144. I am familiar with Rule 144 adopted under the Securities Act, which in some
circumstances permits limited public resales of “restricted securities” like the shares acquired from an issuer in
a non-public offering. I understand that my ability to sell the shares under Rule 144 in the future is uncertain, and may depend
upon, among other things: (i) the availability of certain current public information about the Company; (ii) the resale
occurring more than a specified period after my purchase and full payment (within the meaning of Rule 144) for the shares; and
(iii) if I am an affiliate of the Company (A) the sale being made in an unsolicited “broker’s transaction”,
transactions directly with a market maker or riskless principal transactions, as those terms are defined under the Securities Exchange
Act of 1934, as amended, (B) the amount of shares being sold during any three-month period not exceeding the specified limitations
stated in Rule 144, and (C) timely filing of a notice of proposed sale on Form 144, if applicable.

 

8.             
I know that Rule 144 may never be available. I understand that the requirements of Rule 144 may never
be met, and that the shares may never be saleable under the rule. I further understand that at the time I wish to sell the shares,
there may be no public market for the Company’s stock upon which to make such a sale, or the current public information requirements
of Rule 144 may not be satisfied, either of which may preclude me from selling the shares under Rule 144 even if the
relevant holding period had been satisfied.

 

9.             
I know that I am subject to further restrictions on resale. I understand that in the event Rule 144 is not
available to me, any future proposed sale of any of the shares by me will not be possible without prior registration under the
Securities Act, compliance with some other registration exemption (which may or may not be available), or each of the following:
(i) my written notice to the Company containing detailed information regarding the proposed sale, (ii) my providing an
opinion of my counsel to the effect that such sale will not require registration, and (iii) the Company notifying me in writing
that its counsel concurs in such opinion. I understand that neither the Company nor its counsel is obligated to provide me with
any such opinion. I understand that although Rule 144 is not exclusive, the Staff of the SEC has stated that persons proposing
to sell private placement securities other than in a registered offering or pursuant to Rule 144 will have a substantial burden
of proof in establishing that an exemption from registration is available for such offers or sales, and that such persons and their
respective brokers who participate in such transactions do so at their own risk.

 

10.              
I know that I may have tax liability due to the uncertain value of the shares. I understand that the board
of directors believes its valuation of the shares represents a fair appraisal of their worth, but that it remains possible that,
with the benefit of hindsight, the Internal Revenue Service may successfully assert that the value of the shares on the date of
my purchase is substantially greater than the Board of director’s appraisal. I understand that any additional value ascribed
to the shares by such an IRS determination will constitute ordinary income to me as of the purchase date, and that any additional
taxes and interest due as a result will be my sole responsibility payable only by me, and that the Company need not and will not
reimburse me for that tax liability.

 

11.              
Residence. The address of my principal residence is set forth on the signature page below.

 

12.              
No “bad actor” disqualification events. Neither I nor any person that would be deemed a beneficial
owner of the shares (in accordance with Rule 506(d) of the Securities Act) is subject to any of the “bad actor” disqualifications
described in Rule 506(d)(1)(i) through (viii) under the Securities Act, except as set forth in Rule 506(d)(2)(ii) or
(iii) or (d)(3) under the Securities Act and disclosed, reasonably in advance of the purchase or acquisition of the shares, in
writing in reasonable detail to the Company.

 

By signing below, I
acknowledge my agreement with each of the statements contained in this Investment Representation Statement made as of the date
first set forth above, and my intent for the Company to rely on such statements in issuing the shares to me.

 

    	 	2	 

     

    

 

	 	PURCHASER
	 	 
	 	FASHION FOR GOOD B.V.
	 	a Dutch limited liability company
	 	 
	 	 
	 	 
	 	By:                                                     
	 	Name & Title: Katrin Ley, Managing Director
	 	 
	 	By:                                                     
	 	Name & Title: Angela Schuler-Keiser, General Proxy Holder
	 	 
	 	Address of Purchaser's principal address:
	 	Rokin 102, 1012 KZ Amsterdam, the Netherlands

 

    	 	3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]